JOURNAL OF BUON, cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded)
Purpose: The purpose of this study was to evaluate the association between the rennin-angiotensin system (RAS) inhibition and the risk of breast cancer (BC) recurrence and progression in N3 positive patients.